Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTRA: Moderate vs Aggressive Valsartan + Amlodipine in Hypertension
NCT00666536Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan, amlodipine in hypertension (HTN), sponsored by Novartis. Started Mar 2008; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00666536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666536.